Summary: 103 patients had a second-look operation in the course of management of cancer of the ovary. Patients were stratified according to three indications: (1) resection of the residual tumor following chemotherapy, (2) evaluation of the disease with intents to stop chemotherapy and assess signs of recurrence or persistence, and (3) surgical indication. The first group consisted of 34 patients.
Introduction
Surgery is first step in the management of ovarian malignancies.
After staging and appropriate surgery, ad juvant therapy is usually needed. After adequate chemotherapy it is necessary to assess the tumor response, since the risks of prolonged chemotherapy have now been identified. This assessment celotomy is popularly called a "second-look operation". The purpose of this paper is to describe our experience with the procedure, define its role, and describe the surgical technique for the second-look operation in the management of ovarian cancer.
Methods
In the Department of Obstetrics and Gynecology at Kurume University, approximately 400 patients were treated for ovarian cancer between April 1, 1974, and May 1, 1983 . During this period 103 patients underwent repeat celiotomy. The record of the intial celiotomy was obtained from the referring physician and examined to see that adequate staging and maximal surgery had been performed. 
Results
The 103 patients can be divided into three groups based on the indications for surgery (Table III) .
Group I
Thirty-for patients were reexplored after Group II There were 50 patients explored for this indication. Thirty-five patients in this group originaly had stage I or II , 14 had stage III, and 1 had stage N disease. The interval between celiotomies varied from 6 to 14 mouths, with a mean of 12 months.
No evidence of a tumor was found in 35 of the 50 patients in this group. Terapy was discontinued in these cases. Of the 15 patients who were found to have cancer at the second look, 2 had stage I, 7 had stage II , and 6 had stage i . It is also important to note that cancer recurred in 7 of the 15 patients who had no clinical symptoms before the second-look.
The 5-year survival rate after the second look for patients with no evidence of the disease was 85 %, and 32 % for patients with a macroscopic or microscopic tumor (Fig. II) .
Group III This group consisted of 16 patients who were explored for surgical indicatins : intestinal obstruction, abscess, or fistula. All had residual disease. The outcome was poor; all patients died within 1 year, with a median survival of 4 months.
Complications of the second look operation are listed in Table N . Three patients had a wound infection, 2 had infection of urinary tract, 2 had postopertive intestinal obstruction, 1 had a bowel injury, and 95 had no complications. If residual disease was found, it was excised. Explorations were carried out at 6-month to 1-year intervals until no residual tumor was found, or until the tumor was clearly nonresectable. In Wangensteen's series (Grif f en et al. 1962; Gilbertsen et al. 1963) 14 patients with ovarian carcinoma and positive lymph node metastases underwent 41 operations. Of these 4 had a negative last look and were followed for 47, 60, 63 and 124 months after the last operative procedure. The operative mortality in the total series (excludung hepatectomy) was less than 2 % . This report antedated chemotherapy, yet pointed out the importance of aggressive surgery.
Radiation therapy and new chemotherapeutic regimens have altered the natural history of ovarian carcinoma, and others have reported on the second-look procedure in ovarian carcinoma. The report of Harris et al. (1935) is the oldest. Parks (1945) reported six patients with inoperable ovarian carcinoma, four of whom had complete surgical removal of the tumor following radiation therapy. Kottmeier (1961) performed a similar procedure but reached no definitive conclusion. He belived that incomplete surgical excision could disseminate the disease by opening lymphatic and blood channels and spreading neoplastic cells in the peritoneum.
He also felt that forcible excision of fixed masses could hasten the dissemination of disease.
Tepper and co-workers, in 1971, reported on a series of 17 patients with advanced ovarian carcinoma who were treated with exploratory celiotomy and biopsy, irradiation and chemotherapy, followed by a second look operation.
Of 17 patients, 10 died within 2-years, and 7 patients (41 %) survived for more than 3-years.
Wallach and Blinich (1970) performed a second look operation on eight patients with stage III and N ovarian carcinoma after chemotherapy.
They concluded that this procedure was appropriate for only the small number of patients whose ovaries had been left and who demonstrated complete clinical regression following chemotherapy.
Smith and his colleagues (1972) was the first group to report the results of a planned program of chemotherapy after radical surgery, followed by a second -look operation in responding cases. One hundred and three patients from a trial of 800 cases underwent this operation. Twenty-three patients had no evidence of disease, 46 had a partial response, and 34 had no response. Four of the 23 patients with a negative second look, later died of recurrent carcinoma. The 3-year survival after the second look operation was 41% in stage III and N. Smith updated his results and added more cases (now 186) in 1980, but the survival rates were unchanged.
They also noted that patients with residual tumors less than 2 cm in diameter at the end of the procedure had a 5-year survival of 29.5% . Our equivalent figure is 40%. This is similar to the results of several other investigators.
From a review of the literature and from our own experience, the second look operation can be summarized as follows:
Indication for second look
The secnd-look operation in ovarian cancer can be used for various purposes, which are therapeutic or diagnostic.
The first indication for a second look operation is resection of the residual tumor following therapy. If, complete or incomplete removal of the residual tumor is possible, the survival curve suggests that removal of the residual tumor during the second-look operation improves the survival rate. The second indication is evaluation of the disease with the intent of stopping chemotherapy and assessing signs of early recurrence.
Even if the primary tumor macroscopically seems to be completely removed in the initial operation, the problems of recurrence and the time to stop chemotherapy must always be considered. There is no satisfactory method for this evaluation. In our experience, 7 of the 15 patients who had cancer at the time of the second-look operation were clinically free of the disease prior to the operation.
Technique
The second-look operation should be a carefully planned celiotomy with a clear protocol. The objectives cannot be achieved by laparoscopic examination.
A vertical abdominal incision should be used to obtain adequate exposure. Fluid should be obtained for cytological evaluation upon entering the peritoneal cavity. If no ascites is present, peritoneal washings should be obtained from the pelvis, from both colonic gutters, an from above the liver. The omentum, the para-aortic lymph nodes, and the entire small and large bowels and their mesentery should be examined. The rest of the abdominal viscera should be systematically evaluated, including the stomach, gallblader, spleen, and kidneys. If no disease is present, strips of pelvic peritoneum should be excised for histologic examination.
Biopsies should also be obtained from the sites of the previous disease. If a tumor is present, reduction surgery should be erformed. The aim of surgery is to reduce the size of the largest residual tumor to less than 2 cm in diameter.
